Nocutil (Desmopressin Acetate)

Desmopressin, the active ingredient in Nocutil, is a vasopressin analog presented as a nasal spray for nasal use. It treats central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients.

GNH USA supplies Nocutil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to manage water balance and bleeding disorders.

- Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Hemophilia A: raises plasma factor VIII levels to improve clot formation. - Von Willebrand disease: elevates von Willebrand factor, helping control mucosal bleeding.

Desmopressin nasal spray may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nasal irritation: mild burning or dryness at the application site. - Headache: transient mild to moderate pain. - Hyponatremia: mild reduction in serum sodium, often asymptomatic. - Flushing: brief warmth or redness of the skin.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Thromboembolic events: rare clot formation in veins or arteries. - Allergic reaction: rash, itching, or swelling of the face. - Water intoxication: excessive fluid retention causing edema.

Before prescribing desmopressin nasal spray, clinicians should consider several safety precautions.

- Assess fluid balance: ensure patients are not over‑hydrated to avoid hyponatremia. - Monitor serum sodium: check electrolytes regularly, especially in the elderly or those on diuretics. - Evaluate renal function: impaired kidneys may alter drug clearance. - Caution in cardiac disease: fluid retention can exacerbate heart failure. - Avoid concomitant ADH‑active drugs: limit use with carbamazepine or SSRIs. - Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Desmopressin nasal spray can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may reduce desmopressin effectiveness. - Combination with selective serotonin reuptake inhibitors (SSRIs): increases risk of hyponatremia. - Co‑administration with diuretics (especially thiazides): heightens fluid retention and electrolyte disturbances.

Moderate Interactions (Monitor Closely): - NSAIDs: may potentiate antidiuretic effect, requiring sodium monitoring. - Anticoagulants (e.g., warfarin): enhanced hemostatic effect may alter bleeding risk. - Hormonal contraceptives: possible additive effect on water retention.